NDC 80425-0144-01 - Tizanidine HCL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0144
- Requested NDC
- 80425-0144-01
- Package NDCs from labels
- 80425-0144-3, 80425-0144-2, 80425-0144-1, 80425-0144-4, 80425-0144-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2025-11-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tizanidine HCL - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2025-11-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0144-1 | Tizanidine HCL | 30 in 1 BOTTLE | CAPSULE | 30 | 9 | |
| 80425-0144-2 | Tizanidine HCL | 60 in 1 BOTTLE | CAPSULE | 60 | 9 | |
| 80425-0144-3 | Tizanidine HCL | 90 in 1 BOTTLE | CAPSULE | 90 | 9 | |
| 80425-0144-4 | Tizanidine HCL | 120 in 1 BOTTLE | CAPSULE | 120 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0144 | TIZANIDINE HCL CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 4 package rows | 20250101_c46c7aa3-69db-82dc-e053-2995a90ac251.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0144-1 | EA - Each | 80425-0144 | b99d8b6e-963c-4879-8b61-3267b63e9b19 | 1 | 2023-06-06 |
| 80425-0144-2 | EA - Each | 80425-0144 | 2c88d83a-8c4b-4926-80b5-8419ee8e0ed4 | 1 | 2023-06-06 |
| 80425-0144-3 | EA - Each | 80425-0144 | 4ef89d59-832a-4d98-ae18-e74972a19a02 | 1 | 2023-06-06 |
| 80425-0144-4 | EA - Each | 80425-0144 | 35e993ff-b889-457e-a09e-a02fbef0a6ca | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | Advagen Pharma Limited | 7f39499a-98cf-4d13-9b07-ccb5c22e43c8 | 2026-11-04 | Warnings, Adverse reactions | 485485 485486 485484 B53E3NMY5C |
| Tizanidine | TIZANIDINE | American Health Packaging | 3670f9e3-988d-48e6-9df0-d403d699e08a | 2026-10-30 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fd16a25c-67b6-ae6c-e053-6394a90aeee0 | 2026-10-28 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | PD-Rx Pharmaceuticals, Inc. | fdf4f09d-4537-a438-e053-6394a90a573d | 2026-10-28 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | St. Mary's Medical Park Pharmacy | cfd52c0c-a7c2-e23d-e053-2a95a90abbd1 | 2026-10-23 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | REMEDYREPACK INC. | 17ca23af-c88f-4235-930a-d7568051696f | 2026-10-15 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine | TIZANIDINE | Cardinal Health 107, LLC | eeb18068-75c8-42d0-a006-1b134648333f | 2026-10-06 | Warnings, Adverse reactions | B53E3NMY5C |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ae9b6808-632f-4204-8581-bf146dcab69f | 2026-10-05 | Warnings, Adverse reactions | 485484 B53E3NMY5C |
| TIZANIDINE HYDROCHLORIDE | TIZANIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 6439a7ef-1b22-4fa1-9be3-eedd3cd24191 | 2026-10-05 | Warnings, Adverse reactions | 485485 B53E3NMY5C |
| Tizanidine | TIZANIDINE | Preferred Pharmaceuticals, Inc. | 32c3be66-5398-425c-ac65-e57ba819bb43 | 2026-10-05 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | f0e4eb26-6733-4df6-bb3c-86bf4d976f42 | 2026-10-05 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | Preferred Pharmaceuticals Inc. | 3c993e3c-ee52-45a7-be39-60eaac7a1092 | 2026-10-02 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine | TIZANIDINE | A-S Medication Solutions | 180985f0-3fbd-4868-a826-b84101618a03 | 2026-10-01 | Warnings, Adverse reactions | B53E3NMY5C |
| Tizanidine Hydrochloride | TIZANIDINE HYDROCHLORIDE | Apotex Corp. | 3dd09a0d-a782-1d6d-a552-b71e5bcbf2fe | 2026-09-18 | Warnings, Adverse reactions | 485485 485486 485484 B53E3NMY5C |
| tizanidine | TIZANIDINE | Apotex Corp. | 01c0d3d3-2373-a1b7-822a-80a66291a248 | 2026-09-18 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e19f83b8-8c59-415c-a744-7473d46ab0ca | 2026-09-16 | Warnings, Adverse reactions | 485484 B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e94aa8b1-74ed-46b7-94c5-53d5d5630be6 | 2026-09-16 | Warnings, Adverse reactions | 485486 B53E3NMY5C |
| tizanidine hydrochloride | TIZANIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | d7d5dce0-f8a2-404d-9e87-e2235f5d3268 | 2026-09-16 | Warnings, Adverse reactions | 485485 B53E3NMY5C |
| TIZANIDINE | TIZANIDINE | Aurobindo Pharma Limited | 7ce17c02-7f1f-4d52-8b6f-52e385e12239 | 2026-09-04 | Warnings, Adverse reactions | B53E3NMY5C |
| tizanidine | TIZANIDINE | REMEDYREPACK INC. | 63b7eba3-6dea-4d89-bc42-7e965ae9795d | 2026-08-28 | Warnings, Adverse reactions | B53E3NMY5C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.